Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Medecine Sciences : M/S
|
June 19, 2014
[Economic evaluation in healthcare]
Bruno Detournay
BMJ Open
|
July 29, 2016
Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain
Ignacio Conget, Dídac Mauricio, Rafael Ortega, et al.
Applied Health Economics and Health Policy
|
April 23, 2009
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
Baudouin Standaert, Nathalie Parez, Bertrand Tehard, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 24, 2020
Value of a QALY for France: A New Approach to Propose Acceptable Reference Values
Bertrand Téhard, Bruno Detournay, Isabelle Borget, et al.
Archives of Cardiovascular Diseases
|
December 19, 2022
Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: Insights from the ODYSSEY APPRISE study
Patrick Henry, Bertrand Cariou, Michel Farnier, et al.
Therapie
|
November 25, 2018
Clinical added value of drugs: An empirical survey of French transparency committee opinions
Bruno Detournay, Thomas Borel, Matthieu Trancart, et al.
Pharmacoeconomics - Open
|
November 20, 2020
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
Bruno Detournay, Zahra Boultif, Amar Bahloul, et al.
Therapie
|
May 31, 2021
France's competitiveness in global pharmaceutical research: The situation is improving
Anne d'Andon, Ariane Galaup, Cecile Fabron, et al.
Multiple Sclerosis and Related Disorders
|
September 25, 2020
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017
Patrick Vermersch, Laurent Suchet, Renato Colamarino, et al.
Vascular Health and Risk Management
|
August 1, 2015
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
Bruno Detournay, Serge Halimi, Julien Robert, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Medecine Sciences : M/S
|
June 19, 2014
[Economic evaluation in healthcare]
Bruno Detournay
BMJ Open
|
July 29, 2016
Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain
Ignacio Conget, Dídac Mauricio, Rafael Ortega, et al.
Applied Health Economics and Health Policy
|
April 23, 2009
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
Baudouin Standaert, Nathalie Parez, Bertrand Tehard, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 24, 2020
Value of a QALY for France: A New Approach to Propose Acceptable Reference Values
Bertrand Téhard, Bruno Detournay, Isabelle Borget, et al.
Archives of Cardiovascular Diseases
|
December 19, 2022
Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: Insights from the ODYSSEY APPRISE study
Patrick Henry, Bertrand Cariou, Michel Farnier, et al.
Therapie
|
November 25, 2018
Clinical added value of drugs: An empirical survey of French transparency committee opinions
Bruno Detournay, Thomas Borel, Matthieu Trancart, et al.
Pharmacoeconomics - Open
|
November 20, 2020
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
Bruno Detournay, Zahra Boultif, Amar Bahloul, et al.
Therapie
|
May 31, 2021
France's competitiveness in global pharmaceutical research: The situation is improving
Anne d'Andon, Ariane Galaup, Cecile Fabron, et al.
Multiple Sclerosis and Related Disorders
|
September 25, 2020
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017
Patrick Vermersch, Laurent Suchet, Renato Colamarino, et al.
Vascular Health and Risk Management
|
August 1, 2015
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
Bruno Detournay, Serge Halimi, Julien Robert, et al.
Page
of 6